scholarly journals Trends in Antimicrobial Drug Development: Implications for the Future

2004 ◽  
Vol 38 (9) ◽  
pp. 1279-1286 ◽  
Author(s):  
B. Spellberg ◽  
J. H. Powers ◽  
E. P. Brass ◽  
L. G. Miller ◽  
J. E. Edwards
Keyword(s):  
Drug Development ◽  
Antimicrobial Drug ◽  
The Future

scholarly journals Implementation of a Market Entry Reward within the United States

2018 ◽  
Vol 46 (S1) ◽  
pp. 50-58 ◽  
Author(s):  
Gregory W. Daniel ◽  
Monika Schneider ◽  
Marianne Hamilton Lopez ◽  
Mark B. McClellan
Keyword(s):  
United States ◽  
Health Policy ◽  
Drug Development ◽  
Market Entry ◽  
The United States ◽  
Antimicrobial Drug ◽  
Multifactorial Approach

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to “value-based” payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.

The role of biomarkers in the future of drug development

2006 ◽  
Vol 1 (3) ◽  
pp. 199-204 ◽  
Author(s):  
Scott D Patterson ◽  
Robert F DuBose
Keyword(s):  
Drug Development ◽  
The Future

scholarly journals The future of drug development: the paradigm shift towards systems therapeutics

2018 ◽  
Vol 23 (12) ◽  
pp. 1990-1995 ◽  
Author(s):  
Meindert Danhof ◽  
Kevin Klein ◽  
Pieter Stolk ◽  
Murray Aitken ◽  
Hubert Leufkens
Keyword(s):  
Drug Development ◽  
Paradigm Shift ◽  
The Future
Sign in / Sign up

Export Citation Format

Share Document